欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号BE/H/0084/009
药品名称VIRAFERON
活性成分
    • interferon alpha 2 B 0.0 [no unit]
剂型[not specified]
上市许可持有人N.V. Schering-Plough S.A 73, rue de Stalle B-1180 Bruxelles
参考成员国 - 产品名称Belgium (BE)
互认成员国 - 产品名称
    • Germany (DE)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Denmark (DK)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Luxembourg (LU)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • United Kingdom (Northern Ireland) (XI)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Ireland (IE)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Austria (AT)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • France (FR)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Spain (ES)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Portugal (PT)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Italy (IT)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Greece (GR)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Sweden (SE)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
    • Finland (FI)
      VIRAFERON, HSA free, multi dose vial 25MIU/2,5ml
许可日期2008/04/05
最近更新日期2024/05/28
药物ATC编码
    • A ALIMENTARY TRACT AND METABOLISM
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase